Rockefeller Capital Management L.P.

Position in PAHC — Phibro Animal Health Corp

CIK 1739439 NEW YORK, NY

Back to PAHC Full portfolio

Position in PAHC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$12,433

-$9,911 QoQ

Shares Held

396

-2.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#168

of 207 holders

Holding Since

Jun 2020

11 quarters on record

Voting authority Sole 19% Shared 0% None 81%

Common Shares in PAHC Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Rockefeller Capital Management L.P. holds $105,853,317 across 51 Drug Manufacturers - Specialty & Generic names. PAHC ranks #27 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	373,548	$62,957,776
2	ZTS	Zoetis Inc.	330,418	$23,743,834
3	KNSA	Kiniksa Pharmaceuticals International, plc	173,438	$11,091,360
4	HLN	Haleon plc	122,399	$1,141,981
5	HIMS	Hims & Hers Health, Inc.	29,716	$1,030,252
6	VTRS	Viatris Inc	53,630	$851,642
7	UTHR	UNITED THERAPEUTICS Corp	1,506	$815,994
8	ELAN	Elanco Animal Health Inc	25,940	$638,382

All Filings in PAHC

Export CSV

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$12,433	396	-2.0%	Shares	Defined	2026-08-13
2026-03-31	$22,344	404	+274.1%	Shares	Defined	2026-05-14
2025-12-31	$4,034	108	-3.6%	Shares	Defined	2026-03-17
2025-09-30	$4,531	112	-95.5%	Shares	Defined	2025-11-14
2022-12-31	$33,443	2,494	+24840.0%	Shares	Defined	2023-03-06
2022-09-30	$132	10	-97.5%	Shares	Defined	2022-11-02
2022-06-30	$7,575	396	+2375.0%	Shares	Defined	2022-08-12
2022-03-31	$319	16	0.0%	Shares	Defined	2022-05-13
2021-12-31	$326	16	0.0%	Shares	Defined	2022-02-14
2021-09-30	$344	16	-38.5%	Shares	Defined	2021-11-12
2020-06-30	$683	26	—	Shares	Defined	2020-08-12
No filing history on record for this holder in this stock.